Form 4: Apyx Medical Corp Director Acquires Stock Options
SEC Form 4 Filing
Director Stavros G. Vizirgianakis acquired stock options in Apyx Medical Corp on May 15, 2025.
Summary
- Stavros G. Vizirgianakis, a director of Apyx Medical Corp, filed a Form 4.
- The filing reports a transaction that occurred on May 15, 2025.
- Vizirgianakis acquired 128,000 stock options with an exercise price of $1.48.
- The options vest ratably over twelve months and become fully exercisable on the first anniversary of the grant date.
- The options expire on May 15, 2035.
- Following the transaction, Vizirgianakis directly owns 128,000 derivative securities.
Sentiment
Score: 5
Explanation: Neutral. This is a routine disclosure of stock option grants to a company director.
Industry Context
This is a standard disclosure related to insider transactions, common for publicly traded companies.
Stakeholder Impact
- The granting of stock options aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/15/2025 | Date of stock option grant and transaction. |
| 05/15/2035 | Expiration date of the stock options. |
| 05/19/2025 | Date of Form 4 signature. |
Keywords
Apyx Medical Corp, Stock Options, Form 4, Director, Vizirgianakis, Beneficial Ownership, Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.